Marshall Wace, LLP Procept Bio Robotics Corp Transaction History
Marshall Wace, LLP
- $77.3 Billion
- Q3 2024
A detailed history of Marshall Wace, LLP transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Marshall Wace, LLP holds 15,152 shares of PRCT stock, worth $1.26 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,152
Previous 9,283
63.22%
Holding current value
$1.26 Million
Previous $567,000
113.93%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding PRCT
# of Institutions
266Shares Held
38MCall Options Held
262KPut Options Held
257K-
Vanguard Group Inc Valley Forge, PA4.84MShares$403 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.49MShares$290 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY1.53MShares$128 Million0.04% of portfolio
-
Loomis Sayles & CO L P1.24MShares$103 Million0.13% of portfolio
-
State Street Corp Boston, MA1.18MShares$98.1 Million0.0% of portfolio
About PROCEPT BioRobotics Corp
- Ticker PRCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 44,592,300
- Market Cap $3.71B
- Description
- PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...